Jeffrey J Goates, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 10101 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 720-225-1267 Fax: 720-225-1269 |
Stephen E Howe, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 10101 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 720-225-1267 Fax: 720-225-1269 |
Mr. Randolph Jett Mcmurtry, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 10101 Ridge Gate Parkway, Sky Ridge Medical Center Dept Of Pathology, Lone Tree, CO 80124 Phone: 720-225-1261 |
Carol A Trujillo, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 10101 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 720-225-1267 Fax: 720-225-1269 |
Gregory A Achenbach, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 10101 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 720-225-1267 Fax: 720-225-1269 |
News Archive
Nurses only group with higher risk once community exposure considered. Largest cohort of health care worker risk for SARS CoV-2. Only high-flow oxygen therapy and hemodialysis linked to more antibodies to SARS-CoV-2.
In a small study, researchers reported increased healthy tissue growth after surgical repair of damaged cartilage if they put a "hydrogel" scaffolding into the wound to support and nourish the healing process. The squishy hydrogel material was implanted in 15 patients during standard microfracture surgery, in which tiny holes are punched in a bone near the injured cartilage. The holes stimulate patients' own specialized stem cells to emerge from bone marrow and grow new cartilage atop the bone.
A brain scan with functional MRI (fMRI) is enough to predict which patients with pediatric anxiety disorder will respond to "talk therapy," and so may not need to use psychiatric medication, say neuroscientists from Georgetown University Medical Center.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a Memorandum of Understanding (MoU) with FusionVax, Inc. ("FusionVax") setting forth the main terms under which Advaxis will, subject to the entry of a definitive agreement, exclusively license its lead clinical stage product candidate, ADXS-HPV, to FusionVax for Asia.
› Verified 7 days ago